EUVIMEDEUVIMED entdecken
Crossref

Potentiating Chemo‐Immunotherapy via a Programmable Nanocapsule‐Hydrogel Platform for Sequential Tumor Microenvironment Remodeling

Xiaoyan Qin, Yushu Wang, Yunhao Feng, Hongxia Yuan, Lin Tang, Feifei Li, Zheng Cao, Guang Chen, Ming Zhang, Jing Wen, Chaoyong Liu iD, Yunfeng Lu

Advanced Materials · 2026-03 · 38 (14)

DOI: 10.1002/adma.202522016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 01.02.2026. Verfasst von Xiaoyan Qin und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Organic-Inorganic Composites, Beijing University of Chemical Technology, Beijing, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Nanocapsules, Immunotherapy, Hydrogels. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 88 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Peking University International Hospital Research, Beijing Natural Science Foundation-Changping Innovation Joint Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Durable responses to cancer immunotherapy require both robust antitumor immunity and sustained immune pressure within the immunosuppressive tumor microenvironment (TME). Chemotherapeutics can induce transient immune priming and modulate TME features but are limited by unpredictable immune response durations and systemic toxicity when combined with immunotherapy. To overcome these challenges, we develop a programmable delivery platform integrating chemotherapeutics and immune checkpoint blockade within a silk fibroin hydrogel containing pH‐responsive nanocapsules for controlled temporal release at tumor sites. Leveraging molecular weight differences, the small chemotherapeutic oxaliplatin rapidly diffuses to initiate tumor‐intrinsic immunogenic stress, while the larger anti‐PD‐L1 nanocapsules undergo gradual degradation in the TME, enabling sustained checkpoint engagement. This strategy converts non‐immunogenic tumor cells into a heightened immunogenic state, modulates key immune features of the TME, and supports durable antitumor responses and long‐term central memory T cell persistence in a murine breast tumor model. Our findings demonstrate that this multifunctional platform, combining chemotherapy‐induced immunogenic stress with controlled checkpoint blockade, offers a generalizable approach for designing next‐generation chemo‐immunotherapy combinations in cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentNanocapsulesImmunotherapyHydrogelsAntineoplastic AgentsAnimalsMiceCell Line, TumorFemaleHydrogen-Ion ConcentrationB7-H1 AntigenOxaliplatinImmune Checkpoint Inhibitors

Stichwörter der Autor:innen

pH‐responsive nanocapsulesprogrammable drug deliverysequential chemo‐immunotherapysustained checkpoint engagementtumor microenvironment remodeling

Substanzen

NanocapsulesHydrogelsAntineoplastic AgentsB7-H1 AntigenOxaliplatinImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • State Key Laboratory of Organic-Inorganic Composites, Beijing University of Chemical Technology, Beijing, China.
  • College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
  • Department of Biomedical Engineering, Tufts University, Medford, Massachusetts, USA.
  • Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, China.
  • Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, UCLA AIDS Institute, University of California Los Angeles, Los Angeles, California, USA.
  • Department of Pathology, Peking University International Hospital, Beijing, China.

ORCID-Profile: Chaoyong Liu

Förderung

  • National Key Research and Development Program of China
  • Peking University International Hospital Research
  • Beijing Natural Science Foundation-Changping Innovation Joint Fund

Zitieren

APA

Qin, X., Wang, Y., Feng, Y., Yuan, H., Tang, L., Li, F., Cao, Z., Chen, G., Zhang, M., Wen, J., Liu, C., & Lu, Y. (2026). Potentiating Chemo‐Immunotherapy via a Programmable Nanocapsule‐Hydrogel Platform for Sequential Tumor Microenvironment Remodeling. Advanced Materials, 38(14). https://doi.org/10.1002/adma.202522016

Vancouver

Qin X, Wang Y, Feng Y, Yuan H, Tang L, Li F, et al. Potentiating Chemo‐Immunotherapy via a Programmable Nanocapsule‐Hydrogel Platform for Sequential Tumor Microenvironment Remodeling. Advanced Materials. 2026;38(14). doi:10.1002/adma.202522016

BibTeX
@article{Qin2026,
  author = {Qin, Xiaoyan and Wang, Yushu and Feng, Yunhao and Yuan, Hongxia and Tang, Lin and Li, Feifei and Cao, Zheng and Chen, Guang and Zhang, Ming and Wen, Jing and Liu, Chaoyong and Lu, Yunfeng},
  title = {Potentiating Chemo‐Immunotherapy via a Programmable Nanocapsule‐Hydrogel Platform for Sequential Tumor Microenvironment Remodeling},
  journal = {Advanced Materials},
  year = {2026},
  volume = {38},
  number = {14},
  doi = {10.1002/adma.202522016}
}
Kostenlos starten →